The global continuous glucose monitoring (CGM) systems market is segmented based on component, end user, demographics, and geography. The report includes the revenue generated from the sale of various continuous glucose monitoring systems, but excludes the revenue generated by dealers, traders, or brokers involved in the supply of the systems.Diabetes, a chronic lifestyle disease, is classified into type 1 and type 2 diabetes. In type 1 diabetes, the pancreas is unable to produce sufficient or requisite amount of insulin hormone that is required for metabolizing glucose. In type 2 diabetes, the pancreas produces insulin, but the cells lack the ability to respond and/or do not uptake the insulin available in the blood stream. The symptoms of diabetes include:

 CHAPTER 1: INTRODUCTION 

CHAPTER 2: EXECUTIVE SUMMARY 

CHAPTER 3: MARKET OVERVIEW

CHAPTER 4: CONTINOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT

CHAPTER 5: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS 

CHAPTER 6: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER

CHAPTER 7: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION

CHAPTER 8: COMPANY PROFILES